Finance

Lists
000513:SHE
Livzon Pharmaceutical Group Inc
CNÂ¥26.62
-2.49%
(-0.68) 1D
Sep 11, 3:05:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000513...
Open
CNÂ¥27.28
High
CNÂ¥27.28
Low
CNÂ¥26.55
Mkt. cap
21.39B
Avg. vol.
7.27M
Volume
8.91M
Dividend
5.37%
Quarterly dividend
CNÂ¥0.36
Ex-dividend date
Jun 16, 2026
P/E ratio
14.14
52-wk high
CNÂ¥40.66
52-wk low
CNÂ¥25.74
EPS
CNÂ¥1.88
Shares outstanding
588.10M
No. of employees
9K
Open
CNÂ¥27.28
High
CNÂ¥27.28
Low
CNÂ¥26.55
Mkt. cap
21.39B
Avg. vol.
7.27M
Volume
8.91M
Dividend
5.37%
Quarterly dividend
CNÂ¥0.36
Ex-dividend date
Jun 16, 2026
P/E ratio
14.14
52-wk high
CNÂ¥40.66
52-wk low
CNÂ¥25.74
EPS
CNÂ¥1.88
Shares outstanding
588.10M
No. of employees
9K
News stories
From web sources and news partners
About Livzon Pharmaceutical Group Inc
CEO-
Employees8.88K
FoundedJan 26, 1985
Headquarters-
SectorPharmaceutical industry
Websitelivzon.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.84B
2.90B
2.87B
2.13B
Cost of goods sold
921.58M
1.07B
979.89M
954.72M
Cost of revenue
921.58M
1.07B
979.89M
954.72M
Research and development expenses
251.21M
254.68M
169.43M
188.59M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.02B
1.13B
868.91M
548.97M
Operating expense
1.22B
1.50B
1.06B
779.85M
Total operating expenses
2.15B
2.57B
2.04B
1.73B
Operating income
697.89M
337.97M
835.51M
394.17M
Other non operating income
-5.26M
3.78M
-23.80M
22.57M
EBT including unusual items
668.44M
365.51M
851.71M
474.33M
EBT excluding unusual items
744.09M
362.05M
871.56M
430.85M
Income tax expense
89.40M
84.72M
127.70M
77.42M
Effective tax rate
13.37%
23.18%
14.99%
16.32%
Other operating expenses
-47.89M
121.57M
18.39M
39.13M
Net income
473.01M
269.15M
576.91M
355.29M
Net profit margin
16.63%
9.27%
20.09%
16.69%
Earnings per share
-
-
-
-
Interest and investment income
87.39M
56.74M
69.53M
64.60M
Interest expense
-13.79M
-13.51M
-9.68M
-12.11M
Net interest expenses
73.59M
43.23M
59.85M
52.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
835.21M
474.48M
972.03M
533.65M
Gain or loss from assets sale
-149.72K
3.21M
-
523.14K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps